U.S. Preterm Birth And Prom Testing Market Size & Outlook
Related Markets
U.S. preterm birth and prom testing market highlights
- The U.S. preterm birth and prom testing market generated a revenue of USD 528.3 million in 2024 and is expected to reach USD 1,095.4 million by 2033.
- The U.S. market is expected to grow at a CAGR of 8.5% from 2025 to 2033.
- In terms of segment, ultrasound was the largest revenue generating test type in 2024.
- PAMG-1 Immunoassay is the most lucrative test type segment registering the fastest growth during the forecast period.
Preterm birth and prom testing market data book summary
| Market revenue in 2024 | USD 528.3 million |
| Market revenue in 2033 | USD 1,095.4 million |
| Growth rate | 8.5% (CAGR from 2025 to 2033) |
| Largest segment | Ultrasound |
| Fastest growing segment | PAMG-1 Immunoassay |
| Historical data | 2021 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Pelvic exam, Ultrasound, Biochemical Markers, Uterine Monitoring, Nitazine Test, Ferning Test, Pooling, PAMG-1 Immunoassay, IGFBP Test, Fetal Fibronectin (fFN), Others Test Type |
| Key market players worldwide | Qiagen NV, Hologic Inc, CooperSurgical, Abbott Laboratories, Biosynex, Sera Prognostics, Medix Biochemica, Clinical Innovations, NX Prenatal, IQ Products |
Other key industry trends
- In terms of revenue, U.S. accounted for 33.8% of the global preterm birth and prom testing market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In North America, U.S. preterm birth and prom testing market is projected to lead the regional market in terms of revenue in 2033.
- Canada is the fastest growing regional market in North America and is projected to reach USD 112.6 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Preterm Birth And PROM Testing Market Scope
Preterm Birth And PROM Testing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Biosynex | View profile | 101-250 | Illkirch-graffenstaden, Alsace, France, Europe | http://www.biosynex.com/ |
| Sera Prognostics | View profile | 51-100 | Salt Lake City, Utah, United States, North America | http://www.seraprognostics.com |
| IQ Products | View profile | 11-50 | Groningen, Groningen, The Netherlands, Europe | http://www.iqproducts.nl |
| Clinical Innovations | View profile | 51-100 | Murray, Utah, United States, North America | http://www.clinicalinnovations.com/ |
| Medix Biochemica | View profile | 101-250 | Espoo, Southern Finland, Finland, Europe | https://www.medixbiochemica.com/en/ |
| NX Prenatal | View profile | 1-10 | Louisville, Kentucky, United States, North America | https://www.nxprenatal.com |
| CooperSurgical | View profile | 501-1000 | Trumbull, Connecticut, United States, North America | http://www.coopersurgical.com |
| Hologic Inc | View profile | 6990 | 250 Campus Drive, Marlborough, MA, United States, 01752 | http://www.hologic.com |
| Qiagen NV | View profile | 5900 | Hulsterweg 82, Venlo, LI, Netherlands, 5912 PL | https://www.qiagen.com |
| Abbott Laboratories | View profile | 114000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | https://www.abbottinvestor.com |
U.S. preterm birth and prom testing market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to preterm birth and prom testing market will help companies and investors design strategic landscapes.
Ultrasound was the largest segment with a revenue share of 34.19% in 2024. Horizon Databook has segmented the U.S. preterm birth and prom testing market based on pelvic exam, ultrasound, biochemical markers, uterine monitoring, nitazine test, ferning test, pooling, pamg-1 immunoassay, igfbp test, fetal fibronectin (ffn), others test type covering the revenue growth of each sub-segment from 2021 to 2033.
The CDC also reported that although the rate declined from 2007 to 2014, it has increased since then due to many factors. Some of these factors are multiple pregnancies, consumption of illicit drugs & alcohol, and chronic conditions such as high blood pressure & diabetes.
Babies born preterm are at a greater risk of early death as compared to babies born later in pregnancy. It is one the significant causes of neonatal mortality in the country. Among all the reported cases of preterm births, 80% are unanticipated, 45% to 50% are unknown, and 30% are associated with Preterm Rupture of Membranes (PROM). Therefore, there is rising need for early diagnosis and treatment, facilitating high regional growth.
Reasons to subscribe to U.S. preterm birth and prom testing market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. preterm birth and prom testing market databook
-
Our clientele includes a mix of preterm birth and prom testing market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. preterm birth and prom testing market , including forecasts for subscribers. This country databook contains high-level insights into U.S. preterm birth and prom testing market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. preterm birth and prom testing market size, by biochemical markers, 2018-2030 (US$M)
U.S. Preterm Birth And PROM Testing Market Outlook Share, 2024 & 2033 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
